128 related articles for article (PubMed ID: 35941245)
1. Diagnostic evaluation and incorporation of PSA density and the prostate imaging and data reporting system (PIRADS) version 2 classification in risk-nomograms for prostate cancer.
Rodríguez Cabello MA; Méndez Rubio S; Platas Sancho A; Carballido Rodríguez J
World J Urol; 2022 Oct; 40(10):2439-2450. PubMed ID: 35941245
[TBL] [Abstract][Full Text] [Related]
2. Comparative study between 1.5 and 3 Tesla multiparametric MRI systems using the PIRADS version 2 classification in the diagnosis of prostate cancer.
Cabello MÁR; Rubio SM; Sanz ÁM; Miguelañez JLS; Alba DV; González CA; Sancho AP
Arch Esp Urol; 2022 May; 75(4):330-338. PubMed ID: 35818913
[TBL] [Abstract][Full Text] [Related]
3. Developing a nomogram based on multiparametric magnetic resonance imaging for forecasting high-grade prostate cancer to reduce unnecessary biopsies within the prostate-specific antigen gray zone.
Niu XK; Li J; Das SK; Xiong Y; Yang CB; Peng T
BMC Med Imaging; 2017 Feb; 17(1):11. PubMed ID: 28143433
[TBL] [Abstract][Full Text] [Related]
4. The outcomes of transrectal ultrasound guided biopsy of the prostate in a New Zealand population.
Lienert AR; Davidson PJ; Wells JE
N Z Med J; 2009 Jan; 122(1288):39-49. PubMed ID: 19182841
[TBL] [Abstract][Full Text] [Related]
5. Histological comparison between predictive value of preoperative 3-T multiparametric MRI and
Franklin A; Yaxley WJ; Raveenthiran S; Coughlin G; Gianduzzo T; Kua B; McEwan L; Wong D; Delahunt B; Egevad L; Samaratunga H; Brown N; Parkinson R; Roberts MJ; Yaxley JW
BJU Int; 2021 Jan; 127(1):71-79. PubMed ID: 32524748
[TBL] [Abstract][Full Text] [Related]
6. How to implement magnetic resonance imaging before prostate biopsy in clinical practice: nomograms for saving biopsies.
Borque-Fernando Á; Esteban LM; Celma A; Roche S; Planas J; Regis L; de Torres I; Semidey ME; Trilla E; Morote J
World J Urol; 2020 Jun; 38(6):1481-1491. PubMed ID: 31506748
[TBL] [Abstract][Full Text] [Related]
7. Can combined multiparametric magnetic resonance imaging of the prostate and prostate-specific antigen density improve the detection of clinically significant prostate cancer: A prospective single-center cross-sectional study.
Yadav K; Sureka B; Elhence P; Choudhary GR; Pandey H; Garg PK; Yadav T; Khera PS
J Cancer Res Ther; 2021; 17(2):372-378. PubMed ID: 34121679
[TBL] [Abstract][Full Text] [Related]
8. Prospective study of diagnostic accuracy in the detection of high-grade prostate cancer in biopsy-naïve patients with clinical suspicion of prostate cancer who underwent the Select MDx test.
Lendínez-Cano G; Ojeda-Claro AV; Gómez-Gómez E; Morales Jimenez P; Flores Martin J; Dominguez JF; Amores J; Cozar JM; Bachiller J; Juárez A; Linares R; Garcia Galisteo E; Alvarez Ossorio JL; Requena Tapia MJ; Moreno Jimenez J; Medina Lopez RA;
Prostate; 2021 Sep; 81(12):857-865. PubMed ID: 34184761
[TBL] [Abstract][Full Text] [Related]
9. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
[TBL] [Abstract][Full Text] [Related]
10. A nomogram for prediction of prostate cancer on multi-core biopsy using age, serum prostate-specific antigen, prostate volume and digital rectal examination in Singapore.
Lee A; Lim J; Gao X; Liu L; Chia SJ
Asia Pac J Clin Oncol; 2017 Oct; 13(5):e348-e355. PubMed ID: 27641069
[TBL] [Abstract][Full Text] [Related]
11. Toward an MRI-based nomogram for the prediction of transperineal prostate biopsy outcome: A physician and patient decision tool.
Lee SM; Liyanage SH; Wulaningsih W; Wolfe K; Carr T; Younis C; Van Hemelrijck M; Popert R; Acher P
Urol Oncol; 2017 Nov; 35(11):664.e11-664.e18. PubMed ID: 28801025
[TBL] [Abstract][Full Text] [Related]
12. Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.
Greer MD; Brown AM; Shih JH; Summers RM; Marko J; Law YM; Sankineni S; George AK; Merino MJ; Pinto PA; Choyke PL; Turkbey B
J Magn Reson Imaging; 2017 Feb; 45(2):579-585. PubMed ID: 27391860
[TBL] [Abstract][Full Text] [Related]
13. A novel nomogram combined PIRADS v2 and neutrophil-to-lymphocyte ratio to predict the risk of clinically significant prostate cancer in men with PSA < 10 ng/ml at first biopsy.
Sun J; Zhang Z; OuYang J
Urol Oncol; 2020 May; 38(5):401-409. PubMed ID: 31870724
[TBL] [Abstract][Full Text] [Related]
14. Optimal Prostate Cancer Diagnostic Pathways for Men With Prostatomegaly in the MRI Era.
Gold SA; Goueli R; Mostardeiro TR; Carpinito GP; El-Eishy A; Mauck R; Woldu SL; Strand DW; Lotan Y; Roehrborn CG; Costa DN; Gahan JC
Urology; 2023 Sep; 179():95-100. PubMed ID: 37182648
[TBL] [Abstract][Full Text] [Related]
15. The use of prostate specific antigen density to improve the sensitivity of prostate specific antigen in detecting prostate carcinoma.
Bretton PR; Evans WP; Borden JD; Castellanos RD
Cancer; 1994 Dec; 74(11):2991-5. PubMed ID: 7525040
[TBL] [Abstract][Full Text] [Related]
16. Evaluating the performance of clinical and radiological data in predicting prostate cancer in prostate imaging reporting and data system version 2.1 category 3 lesions of the peripheral and the transition zones.
Gaudiano C; Bianchi L; Corcioni B; Giunchi F; Schiavina R; Ciccarese F; Braccischi L; Rustici A; Fiorentino M; Brunocilla E; Golfieri R
Int Urol Nephrol; 2022 Feb; 54(2):263-271. PubMed ID: 34822065
[TBL] [Abstract][Full Text] [Related]
17. [Prospective validation of a nomogram predictive of a positive initial prostate biopsy].
Ramírez-Backhaus M; Bahilo P; Arlandis S; Santamaría Navarro C; Pontones Moreno JL; Jiménez-Cruz F
Actas Urol Esp; 2010 Jan; 34(1):35-42. PubMed ID: 20223131
[TBL] [Abstract][Full Text] [Related]
18. Clinical parameters and nomograms for predicting lymph node metastasis detected with
Onal C; Ozyigit G; Oymak E; Guler OC; Hurmuz P; Tilki B; Reyhan M; Tuncel M; Akyol F
Prostate; 2021 Jul; 81(10):648-656. PubMed ID: 33949694
[TBL] [Abstract][Full Text] [Related]
19. Qualitative and Quantitative Reporting of a Unique Biparametric MRI: Towards Biparametric MRI-Based Nomograms for Prediction of Prostate Biopsy Outcome in Men With a Clinical Suspicion of Prostate Cancer (IMPROD and MULTI-IMPROD Trials).
Perez IM; Jambor I; Kauko T; Verho J; Ettala O; Falagario U; Merisaari H; Kiviniemi A; Taimen P; Syvänen KT; Knaapila J; Seppänen M; Rannikko A; Riikonen J; Kallajoki M; Mirtti T; Lamminen T; Saunavaara J; Pahikkala T; Boström PJ; Aronen HJ
J Magn Reson Imaging; 2020 May; 51(5):1556-1567. PubMed ID: 31750988
[TBL] [Abstract][Full Text] [Related]
20. Who Benefits from Multiparametric Magnetic Resonance Imaging After Suspicion of Prostate Cancer?
Morote J; Celma A; Roche S; de Torres IM; Mast R; Semedey ME; Regis L; Planas J
Eur Urol Oncol; 2019 Nov; 2(6):664-669. PubMed ID: 31411977
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
